SAN DIEGO, June 02, 2025 -- BioAtla, Inc. (Nasdaq: BCAB) (the “Company”), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the...
Art Pappas will participate on a panel called "Venture Capital and Private Equity - How Do You Look for the Next Big Investment" at the Drug Delivery Partnerships conference in Las Vegas, NV
News | 01. 22. 2009
© 2025 Pappas Capital, LLC. ALL RIGHTS RESERVED.